American Oriental Bioengineering (AOB) Stock Quote

Detailed Quote for American Oriental Bioengineering (AOB)

close 52 Week Information

52 Week High

February 14, 2011

Close: 2.37

52 Week Low

October 4, 2011

Close: 0.50

Today

5d

1m

3m

1y

more

Last Price
0.8317

Change $
0.0184

Change %
2.16%

Tick
N/A

Bid
0.75

Bid Size
2,000

Ask
0.91

Ask Size
1,400

Open
0.84

High
0.86

Low
0.82

Prev Close
0.8501

Last Trade
2/10/12

Volume
170.3 k

52 Wk Hi
2.37

52 Wk Low
0.50

Market Cap
65.29 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
78,503,381

EPS (TTM)
0.20

PE Ratio
4.20

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for American Oriental Bioengineering (AOB)

Sector News | Topic News

News for AOB

Mon, Nov 14, 2011

6:03 PM

American Oriental Bioengineering Reports Third Quarter 2011 Financial Results - PR Newswire

5:25 PM

American Oriental Bioengineering to Hold Third Quarter 2011 Earnings Conference Call at 8:00 AM on November 15, 2011 - PR Newswire

Tue, Nov 08, 2011

2:58 PM

American Oriental Bioengineering Delays Release of its Third Quarter 2011 Financial Results and Earnings Conference Call - PR Newswire

Thu, Nov 03, 2011

9:15 AM

American Oriental Bioengineering to Announce Third Quarter 2011 Financial Results on November 8, 2011 - PR Newswire

Thu, Oct 06, 2011

5:00 PM

American Oriental Bioengineering, Inc. Submitted Its Plan to Cure Stock Price Deficiency with Respect to NYSE Listing Standard - PR Newswire

Tue, Sep 27, 2011

4:30 PM

American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard - PR Newswire

More News for AOB >>

Tags for American Oriental Bioengineering

Research stocks or mutual funds related to American Oriental Bioengineering by keywords or tags. Find companies that have a similar focus to AOB. The keywords below have been associated to AOB by either user submission or electronic means.

organizational change organization culture biotech research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment investment products pharmaceutical patents organizational culture biotechnology market pharmaceutical research and development pharmaceutical manufacturing company pharma marketing pharmaceutical industry marketing organizational development pharmaceutical software pharma manufacturing pharma license kv pharmaceutical company gmp pharmaceutical pharmaceutical fraud generic products active pharmaceutical ingredient pharmaceutical cro pharma consulting active pharmaceutical ingredients pharmaceutical promotion pharmaceutical sales pharma pharmaceutical distributors pharmaceutical marketing internship pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharmaceutical consultant biotech pharmaceutical patent Drugs pharmaceutical auctions pharmaceutical industry news pharmaceutical manufacturing software biotechnology careers pharmaceutical manufacturing pharmaceutical translations pharmaceutical formulation pharmaceutical engineering contract pharmaceutical pharmaceutical consulting

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.